Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$5.65bn	985.32	n/a
CU6Clarity Pharmaceuticals	AU$1.41bn	n/a	n/a
MSBMesoblast	AU$1.06bn	n/a	n/a
IMMImmutep	AU$543.15m	n/a	n/a
IMUImugene	AU$430.15m	n/a	n/a
PYCPYC Therapeutics	AU$410.62m	n/a	n/a
OPTOpthea	AU$321.46m	n/a	n/a
RACRace Oncology	AU$291.84m	n/a	n/a
DXBDimerix	AU$245.05m	n/a	n/a
CGSCogstate	AU$197.07m	25.97	n/a
ALAArovella Therapeutics	AU$118.25m	n/a	n/a
PIQProteomics International Laboratories	AU$116.22m	n/a	n/a
LTPLtr Pharma	AU$112.23m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$86.12m	n/a	n/a
ACWActinogen Medical	AU$84.39m	n/a	n/a
PERPercheron Therapeutics	AU$75.73m	n/a	n/a
AGNArgenica Therapeutics	AU$71.88m	n/a	n/a
PEBPacific Edge	NZ$77.88m	n/a	n/a
OCCOrthocell	AU$71.74m	n/a	n/a
CYPCynata Therapeutics	AU$53.89m	n/a	n/a